Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniel E Felsing

Showing results (1-10 of 15) with videos related to

Pageof 2
Sort By:
European Journal of Pharmacology|January 29, 2019
Ligand-directed serotonin 5-HT<sub>2C</sub> receptor desensitization and sensitizationDaniel E Felsing, Clinton E Canal, Raymond G Booth
Current Topics in Medicinal Chemistry|September 26, 2019
Advances in Dopamine D1 Receptor Ligands for NeurotherapeuticsDaniel E Felsing, Manish K Jain, John A Allen
Biorxiv : the Preprint Server for Biology|April 25, 2024
Functionally selective dopamine D1 receptor endocytosis and signaling by catechol and non-catechol agonistsAshley N Nilson, Daniel E Felsing, Pingyuan Wang, et al.
ACS Medicinal Chemistry Letters|June 16, 2022
Retraction of "Synthesis and Pharmacological Evaluation of Noncatechol G Protein Biased and Unbiased Dopamine D1 Receptor Agonists"Pingyuan Wang, Daniel E Felsing, Haiying Chen, et al.
ACS Medicinal Chemistry Letters|May 18, 2019
Synthesis and Pharmacological Evaluation of Noncatechol G Protein Biased and Unbiased Dopamine D1 Receptor AgonistsPingyuan Wang, Daniel E Felsing, Haiying Chen, et al.
Epilepsy Research|June 15, 2021
Evaluation of lorcaserin as an anticonvulsant in juvenile Fmr1 knockout miceTanishka S Saraf, Daniel E Felsing, Jessica L Armstrong, et al.
Biochemistry|March 20, 2025
Functionally Selective Dopamine D1 Receptor Endocytosis and Signaling by Catechol and Noncatechol AgonistsAshley N Nilson, Daniel E Felsing, Pingyuan Wang, et al.
Plos One|August 30, 2018
Biophysical validation of serotonin 5-HT2A and 5-HT2C receptor interactionDaniel E Felsing, Noelle C Anastasio, Joanna M Miszkiel, et al.
Journal of Medicinal Chemistry|May 24, 2024
Discovery of 3-((4-Benzylpyridin-2-yl)amino)benzamides as Potent GPR52 G Protein-Biased AgonistsRyan E Murphy, Pingyuan Wang, Saghir Ali, et al.
ACS Chemical Neuroscience|May 27, 2015
An Orally Active Phenylaminotetralin-Chemotype Serotonin 5-HT7 and 5-HT1A Receptor Partial Agonist that Corrects Motor Stereotypy in Mouse ModelsClinton E Canal, Daniel E Felsing, Yue Liu, et al.
Pageof 2

Showing results (1-10 of 15) with videos related to

Sort By:
Pageof 2
European Journal of Pharmacology|January 29, 2019
Ligand-directed serotonin 5-HT<sub>2C</sub> receptor desensitization and sensitizationDaniel E Felsing, Clinton E Canal, Raymond G Booth
Current Topics in Medicinal Chemistry|September 26, 2019
Advances in Dopamine D1 Receptor Ligands for NeurotherapeuticsDaniel E Felsing, Manish K Jain, John A Allen
Biorxiv : the Preprint Server for Biology|April 25, 2024
Functionally selective dopamine D1 receptor endocytosis and signaling by catechol and non-catechol agonistsAshley N Nilson, Daniel E Felsing, Pingyuan Wang, et al.
ACS Medicinal Chemistry Letters|June 16, 2022
Retraction of "Synthesis and Pharmacological Evaluation of Noncatechol G Protein Biased and Unbiased Dopamine D1 Receptor Agonists"Pingyuan Wang, Daniel E Felsing, Haiying Chen, et al.
ACS Medicinal Chemistry Letters|May 18, 2019
Synthesis and Pharmacological Evaluation of Noncatechol G Protein Biased and Unbiased Dopamine D1 Receptor AgonistsPingyuan Wang, Daniel E Felsing, Haiying Chen, et al.
Epilepsy Research|June 15, 2021
Evaluation of lorcaserin as an anticonvulsant in juvenile Fmr1 knockout miceTanishka S Saraf, Daniel E Felsing, Jessica L Armstrong, et al.
Biochemistry|March 20, 2025
Functionally Selective Dopamine D1 Receptor Endocytosis and Signaling by Catechol and Noncatechol AgonistsAshley N Nilson, Daniel E Felsing, Pingyuan Wang, et al.
Plos One|August 30, 2018
Biophysical validation of serotonin 5-HT2A and 5-HT2C receptor interactionDaniel E Felsing, Noelle C Anastasio, Joanna M Miszkiel, et al.
Journal of Medicinal Chemistry|May 24, 2024
Discovery of 3-((4-Benzylpyridin-2-yl)amino)benzamides as Potent GPR52 G Protein-Biased AgonistsRyan E Murphy, Pingyuan Wang, Saghir Ali, et al.
ACS Chemical Neuroscience|May 27, 2015
An Orally Active Phenylaminotetralin-Chemotype Serotonin 5-HT7 and 5-HT1A Receptor Partial Agonist that Corrects Motor Stereotypy in Mouse ModelsClinton E Canal, Daniel E Felsing, Yue Liu, et al.
Pageof 2